Tcino Bioscience
Yongin
About Tcino Bioscience
Tcino Bioscience develops molecule anti-cancer drugs for cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2023)
- Website: txinno.com
- Phone: +82 82 31 778 8688
Industries & Categories
Biotechnology, Medical, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/tcino-bioscience-11802 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.